pembrolizumab

You have access
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
TETSUYA YUMIOKA, MASASHI HONDA, RYUTARO SHIMIZU, SHOGO TERAOKA, NORIYA YAMAGUCHI, BUNYA KAWAMOTO, HIDETO IWAMOTO, SHUICHI MORIZANE, KATSUYA HIKITA and ATSUSHI TAKENAKA

Anticancer Research November 2021, 41 (11) 5767-5773; DOI: https://doi.org/10.21873/anticanres.15393
You have access
Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report
YOSUKE SHIONOYA, YOSHIHIKO HIROHASHI, HARUKA TAKAHASHI, MIDORI HASHIMOTO, KAORU NISHIYAMA, YASUNARI TAKAKUWA, MUNEHIDE NAKATSUGAWA, TERUFUMI KUBO, TAKAYUKI KANASEKI, TOMOHIDE TSUKAHARA and TOSHIHIKO TORIGOE

Anticancer Research July 2021, 41 (7) 3699-3706; DOI: https://doi.org/10.21873/anticanres.15161
You have access
Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
YOSHIFUMI KADONO, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, TAIKI KAMIJIMA, CHIKASHI SETO, AKINOBU TAKANO, SATOSHI YOTSUYANAGI, RYUNOSUKE NAKAGAWA, TOHRU MIYAGI, SHUHEI AOYAMA, HIDEKI ASAHI, RIE FUKUDA and ATSUSHI MIZOKAMI

Anticancer Research March 2021, 41 (3) 1599-1606; DOI: https://doi.org/10.21873/anticanres.14921
You have access
Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
YUDAI ISHIYAMA, TSUNENORI KONDO, YUKI NEMOTO, YUKI KOBARI, HIROKI ISHIHARA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, YASUNOBU HASHIMOTO, TOSHIO TAKAGI, JUNPEI IIZUKA and KAZUNARI TANABE

Anticancer Research March 2021, 41 (3) 1607-1614; DOI: https://doi.org/10.21873/anticanres.14922
You have access
Complete Response of Bone Metastasis in Non-small Cell Lung Cancer With Pembrolizumab: Two Case Reports
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, HIROTAKA YONEZAWA, YOSHIHIRO ARAKI, SEI MORINAGA, KAZUO KASAHARA, TAKASHI SONE and HIROYUKI TSUCHIYA

Anticancer Research March 2021, 41 (3) 1693-1699; DOI: https://doi.org/10.21873/anticanres.14933
You have access
Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma
JANICE B. HU, SURYA RAVICHANDRAN, CHRISTEL RUSHING, GEORGIA M. BEASLEY, BRENT A. HANKS, SIN-HO JUNG, APRIL K.S. SALAMA, LISA HO and PAUL J. MOSCA

Anticancer Research September 2020, 40 (9) 5245-5254; DOI: https://doi.org/10.21873/anticanres.14528
You have access
Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report
MASASHI NAKAMURA, MASAKI UENO, SHINYA HAYAMI, MANABU KAWAI, ATSUSHI MIYAMOTO, NORIHIKO SUZAKI, SEIKO HIRONO, KEN-ICHI OKADA, MOTOKI MIYAZAWA, YUJI KITAHATA, RYOHEI KOBAYASHI, FUMIYOSHI KOJIMA and HIROKI YAMAUE

Anticancer Research July 2020, 40 (7) 4123-4129; DOI: https://doi.org/10.21873/anticanres.14411
You have access
Pembrolizumab and Radiotherapy for Platinum-refractory Recurrent Uterine Carcinosarcoma With an Abscopal Effect: A Case Report
MITSUTAKE YANO, SAKI ASO, MIHO SATO, YOKO AOYAGI, HARUNOBU MATSUMOTO and KAEI NASU

Anticancer Research July 2020, 40 (7) 4131-4135; DOI: https://doi.org/10.21873/anticanres.14412
You have access
Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab
LUKA SIMETIĆ, KREŠIMIR BLAŽIČEVIĆ, KATA MEĐUGORAC, MARIN GOLČIĆ and DAVORIN HERCEG

Anticancer Research April 2020, 40 (4) 2157-2163; DOI: https://doi.org/10.21873/anticanres.14175
You have access
Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer
TSUKASA HASEGAWA, NORIKO YANAGITANI, HIROFUMI UTSUMI, HIROSHI WAKUI, HIROAKI SAKAMOTO, TAKEHIRO TOZUKA, HIROSHI YOSHIDA, YOSHIAKI AMINO, SHINYA UEMATSU, TAKAHIRO YOSHIZAWA, KEN UCHIBORI, SATORU KITAZONO, ATSUSHI HORIIKE, TAKESHI HORAI, KAZUYOSHI KUWANO and MAKOTO NISHIO

Anticancer Research December 2019, 39 (12) 6851-6857; DOI: https://doi.org/10.21873/anticanres.13902

Main menu

User menu

Search

pembrolizumab

Pages